Claim: £280 million of taxpayers' money is going to Lilly to fund the NHS weight loss injection trial.
Fact-check: Weight loss drug trial isn't being funded with public money - Full Fact
Verdict: this is incorrect. the five-year trial into the use of tirzepatide for people living with obesity will be funded entirely by the pharmaceutical company lilly.
Organisation: Full Fact
Author: Jess Hacker
Date published: 2024-10-23T00:00:00